Hodgkin lymphoma
A clinical research conducted to study the tolerance and efficacy of two medicines namely Bendamustine and Nivolumab which are used for treatment of relapse or non-responsive type of Hodgkins Lymphoma (a type of blood cancer) in children and young adults
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 2: does it work?
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial HospitalMumbaiDirections ↗
Registry summary (technical)
Phase II Study of Bendamustine and fixed dose Nivolumab in Children and young adults with Relapsed or Refractory Hodgkin Lymphoma - NIL
Sponsor: Dr Shyam Srinivasan
CTRI/2025/06/088241 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Aug 2026 · read by us 5 Nov 2026